Compare PSIX & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSIX | ANIP |
|---|---|---|
| Founded | 1985 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | N/A | N/A |
| Metric | PSIX | ANIP |
|---|---|---|
| Price | $86.27 | $76.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $98.76 | ★ $107.33 |
| AVG Volume (30 Days) | 407.9K | ★ 459.0K |
| Earning Date | 03-13-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.27 | N/A |
| EPS | ★ 5.26 | 1.67 |
| Revenue | $675,481,000.00 | ★ $826,880,000.00 |
| Revenue This Year | $50.35 | $44.19 |
| Revenue Next Year | $20.10 | $11.25 |
| P/E Ratio | ★ $15.88 | $47.71 |
| Revenue Growth | ★ 54.78 | 48.87 |
| 52 Week Low | $18.10 | $54.10 |
| 52 Week High | $121.78 | $99.50 |
| Indicator | PSIX | ANIP |
|---|---|---|
| Relative Strength Index (RSI) | 62.31 | 35.03 |
| Support Level | $65.96 | $78.38 |
| Resistance Level | $87.50 | $83.80 |
| Average True Range (ATR) | 6.44 | 2.77 |
| MACD | 0.94 | -0.45 |
| Stochastic Oscillator | 93.33 | 0.10 |
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.